K2 Venture Partners

K2 Venture Partners

Beijing, Beijingk2vc.com

Overview

K2 Venture Partners is a venture capital fund managed by the parent firm K2VC (险峰). Founded in 2016, it focuses on early-stage investments in BioTech, MedTech, and life-science companies. The parent firm, K2VC, was founded in 2010 and also manages K2 Angel Partners, which invests in technology and consumer sectors. The firm supports scientists and entrepreneurs in translating innovative technologies into high-impact applications and serves as a long-term partner.

Portfolio Companies

6

Website

k2vc.com

Investments

CompanyDateStageLead
Sanegene BioDec 2025Series BCo-investor
LTZ TherapeuticsJul 2024Series ACo-investor
Aureka BiotechnologiesMar 2024SeedLead
LTZ TherapeuticsMay 2023Early FundingCo-investor
SironaxAug 2022Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.